KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Amortization of Deferred Charges: 2010-2025

Historic Amortization of Deferred Charges for Tenet Healthcare (THC) over the last 16 years, with Q3 2025 value amounting to $6.0 million.

  • Tenet Healthcare's Amortization of Deferred Charges fell 1428.57% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.0 million, marking a year-over-year decrease of 1724.14%. This contributed to the annual value of $26.0 million for FY2024, which is 1875.0% down from last year.
  • Latest data reveals that Tenet Healthcare reported Amortization of Deferred Charges of $6.0 million as of Q3 2025, which was down 1428.57% from $6.0 million recorded in Q2 2025.
  • In the past 5 years, Tenet Healthcare's Amortization of Deferred Charges registered a high of $10.0 million during Q4 2022, and its lowest value of $5.0 million during Q4 2024.
  • For the 5-year period, Tenet Healthcare's Amortization of Deferred Charges averaged around $7.5 million, with its median value being $8.0 million (2021).
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first skyrocketed by 2857.14% in 2023, then crashed by 3333.33% in 2024.
  • Over the past 5 years, Tenet Healthcare's Amortization of Deferred Charges (Quarter) stood at $8.0 million in 2021, then rose by 25.0% to $10.0 million in 2022, then decreased by 30.0% to $7.0 million in 2023, then dropped by 28.57% to $5.0 million in 2024, then grew by 20.0% to $6.0 million in 2025.
  • Its Amortization of Deferred Charges stands at $6.0 million for Q3 2025, versus $6.0 million for Q2 2025 and $6.0 million for Q1 2025.